From: Impact of vitamin D levels on mortality in older covid-19 vaccinated patients
Model | Outcome | Variable | HR | p-value | IC 95% | |
---|---|---|---|---|---|---|
 |  |  |  |  | Lower limit | Upper limit |
1 | Mortality per 1 point increase in variable or per specified category | Age [years] | 1 | 0.66 | 0.94 | 1.04 |
Gender F | 1.47 | 0.32 | 0.68 | 3.17 | ||
Vitamin D levels | Â | Â | Â | Â | ||
25–50 nmol/L | 2.91 | 0.02 | 1.51 | 7.37 | ||
> 50 nmol/L | 0.47 | 0.17 | 0.21 | 1.06 | ||
2 | Mortality per 1 point increase in variable or per specified category | Age [years] | 0.9 | 0.07 | 0.8 | 1.01 |
Gender F | 1.59 | 0.45 | 0.47 | 5.38 | ||
MPI | 3.94 | 0.13 | 0.38 | 4.17 | ||
Length of stay | 1.02 | 0.51 | 0.97 | 1.06 | ||
Sarcopenia | 3.81 | 0.03 | 2.1 | 4.5 | ||
Vitamin D levels | Â | Â | Â | Â | ||
25–50 nmol/L | 4.52 | 0.04 | 1.04 | 7.73 | ||
> 50 nmol/L | 0.43 | 0.19 | 0.12 | 1.51 |